CNS tumours
Invited discussant abstracts 326PD, 327PD and 328PD
Date
08 Oct 2016Session
CNS tumoursPresenters
Andreas HottingerAuthors
A. HottingerAuthor affiliations
- Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois - CHUV, 1011 - Lausanne/CH
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
3798 - The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas
Presenter: Mark Kieran
Session: CNS tumours
Resources:
Abstract
2123 - Clinical risk or molecular risk: What matters in low grade gliomas? A study from the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
Presenter: Enrico Franceschi
Session: CNS tumours
Resources:
Abstract
3734 - ANG1005, a novel peptide-paclitaxel conjugate crosses the BBB and shows activity in patients with recurrent CNS metastasis from breast cancer, results from a phase II clinical study
Presenter: Shou-Ching Tang
Session: CNS tumours
Resources:
Abstract
2882 - Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost, mass spectrometry-based DNA methylomics
Presenter: Ed Schwalbe
Session: CNS tumours
Resources:
Abstract
1309 - Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM)
Presenter: Andrew Lassman
Session: CNS tumours
Resources:
Abstract
2390 - PD-L1 and IL17 expression in tumor infiltrating lymphocytes are opposite prognostic factors in glioblastoma
Presenter: Estelle Bronsart
Session: CNS tumours
Resources:
Abstract
2763 - Effectiveness of antiangiogenic drugs (ADs) in glioblastoma (GBM) patients (PTS): a metanalysis of randomized clinical trials (RCTs)
Presenter: Giuseppe Lombardi
Session: CNS tumours
Resources:
Abstract
2078 - Survival of patients with synchronous and metachronous breast cancer and meningioma
Presenter: Catarina Ribeiro
Session: CNS tumours
Resources:
Abstract
2652 - Temporal muscle thickness (TMT) is an independent prognostic parameter in patients with newly diagnosed brain metastases (BM) of breast cancer (BC)
Presenter: Anna Sophie Berghoff
Session: CNS tumours
Resources:
Abstract
3029 - Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
Presenter: Christian Grommes
Session: CNS tumours
Resources:
Abstract